Rajvir Dahiya

Rajvir Dahiya (born May 30, 1956) is an American Indian medical oncology scientist with expertise in urology oncology diagnosis, prognosis and risk assessment through genetic and epigenetic technology. Dahiya retired in 2021 as a Professor Emeritus and Director of Urology Oncology Research Center at the Veterans Affairs Medical Center and the University of California San Francisco School of Medicine (UCSF) after 34 years of service.

After retirement, Dahiya founded [https://geneverify.org/ Geneverify Inc]. in 2021, a company registered in California, USA. The company is dedicated to research and development in precision oncology, particularly in the creation of in vitro diagnostic tests for cancer screening, early diagnosis, prognosis, and treatment follow-up. Geneverify is also working on developing novel medical technologies that target oncogenes, aiming to provide the most effective and highly specific treatments for various cancers, potentially saving the lives of millions of cancer patients. Provided by Wikipedia